RETEVMO
Drug
Lilly USA, LLC
Total Payments
$1.1M
Transactions
5,166
Doctors
2,685
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $122,792 | 345 | 283 |
| 2023 | $375,085 | 2,324 | 1,418 |
| 2022 | $539,935 | 1,647 | 819 |
| 2021 | $23,457 | 611 | 466 |
| 2020 | $4,482 | 239 | 219 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $776,288 | 374 | 72.8% |
| Consulting Fee | $121,863 | 50 | 11.4% |
| Food and Beverage | $120,081 | 4,298 | 11.3% |
| Travel and Lodging | $25,363 | 253 | 2.4% |
| Education | $22,158 | 191 | 2.1% |
Top Doctors Receiving Payments for RETEVMO
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Hematology & Oncology | Orlando, FL | $133,528 | 115 |
| , M.D | Internal Medicine | Richmond, KY | $61,649 | 58 |
| , M.D | Hematology & Oncology | Scottsdale, AZ | $59,062 | 81 |
| , MD | Hematology & Oncology | Aventura, FL | $58,140 | 55 |
| , MD | Hematology & Oncology | Orlando, FL | $51,734 | 39 |
| , MD | Hematology & Oncology | Encino, CA | $51,696 | 107 |
| , M.D., PH.D | Student in an Organized Health Care Education/Training Program | Altamonte Springs, FL | $49,028 | 50 |
| , M.D | Specialist | San Francisco, CA | $47,360 | 41 |
| , MD | Medical Oncology | Mcallen, TX | $44,442 | 62 |
| , MD | Hematology & Oncology | Dayton, OH | $34,118 | 44 |
| , MD | Endocrinology, Diabetes & Metabolism | Lehi, UT | $28,464 | 42 |
| , MD | Hematology & Oncology | Conroe, TX | $26,767 | 37 |
| , M.D | Hematology & Oncology | Beverly Hills, CA | $24,075 | 27 |
| , M.D | Medical Oncology | Indianapolis, IN | $21,657 | 27 |
| Bryan Mc Iver | — | Rochester, MN | $16,650 | 13 |
| , MD | Medical Oncology | Dallas, TX | $14,754 | 17 |
| , MD | Hematology | Stamford, CT | $12,747 | 26 |
| , MD | Hematology & Oncology | Binghamton, NY | $12,166 | 16 |
| , MD | Medical Oncology | Austin, TX | $12,000 | 17 |
| , MD | Hematology & Oncology | Altamonte Springs, FL | $11,774 | 10 |
| , M.D | Oncology | San Juan, PR | $11,677 | 27 |
| , MD | Hematology & Oncology | Boca Raton, FL | $11,494 | 20 |
| , MD | Hematology & Oncology | Nashville, TN | $10,879 | 9 |
| , M.D., M.P.H | Internal Medicine | Jeffersonville, IN | $9,157 | 8 |
| , M.D | Medical Oncology | Greensboro, NC | $8,527 | 20 |
Ad
Manufacturing Companies
- Lilly USA, LLC $993,077
- Eli Lilly and Company $57,721
- Eli Lilly Export S.A. Puerto Rico Branch $14,954
Product Information
- Type Drug
- Total Payments $1.1M
- Total Doctors 2,685
- Transactions 5,166
About RETEVMO
RETEVMO is a drug associated with $1.1M in payments to 2,685 healthcare providers, recorded across 5,166 transactions in the CMS Open Payments database. The primary manufacturer is Lilly USA, LLC.
Payment data is available from 2020 to 2024. In 2024, $122,792 was paid across 345 transactions to 283 doctors.
The most common payment nature for RETEVMO is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($776,288, 72.8% of total).